导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.74% | 378/746 |
| 近一周 | 0.05% | 447/862 |
| 近一月 | 0.03% | 141/856 |
| 近一季 | 0.56% | 183/829 |
| 近半年 | 0.70% | 418/795 |
| 近一年 | 2.78% | 242/744 |
| 近两年 | 9.31% | 168/632 |
| 近三年 | 16.76% | 48/579 |
| 成立以来 | 87.84% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-0.07% 31/67 |
- - |
-0.35% 647/871 |
- - |
| 2024 | 6.53% 103/819 |
1.96% 177/3226 |
2.14% 93/3360 |
-0.60% 733/800 |
2.91% 142/819 |
| 2023 | 12.89% 16/3108 |
9.54% 9/2776 |
1.17% 1420/2849 |
0.56% 1125/2940 |
1.29% 338/3108 |
| 2022 | -5.33% 2343/2726 |
- - |
- - |
-5.60% 2494/2598 |
-3.30% 2563/2732 |
| 2021 | 7.52% 82/2409 |
1.28% 155/2074 |
2.63% 49/2672 |
1.97% 227/2733 |
1.45% 431/2803 |
| 2020 | 0.11% 1636/2196 |
3.65% 45/1576 |
-0.01% 644/2274 |
0.15% 806/2477 |
-3.56% 2440/2565 |
| 2019 | 5.76% 159/1720 |
1.79% 169/605 |
0.71% 326/637 |
2.45% 29/1762 |
0.71% 1502/1956 |
| 2018 | 9.21% 52/1267 |
- - |
- - |
- - |
4.17% 13/593 |
| 2017 | 1.13% 518/1017 |
- - |
- - |
- - |
- - |
| 2016 | 1.97% 147/769 |
- - |
- - |
- - |
- - |
| 2015 | 13.62% 56/377 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 天弘稳利定期开放A VS. () |